Uncategorized

AscellaHealth Launches Q3 2023 Specialty & Rare Pipeline Digest™: Expert Resource for FDA Approval Status of Specialty Pharmaceuticals and Cell & Gene Therapies

by Business Wire • 2023/09/28 • 0 Comments

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Launches Q3 2023 Specialty & Rare Pipeline Digest™: Expert Resource for FDA Approval Status of Specialty Pharmaceuticals & CGT

← VIDEO: Handheld femtosecond laser performs precise capsulorrhexis in milliseconds

VIDEO: What to do when capsular support is not an option →

Post navigation